The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
Finance

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

MAY 9, 2019
Pharmabiotics 2019 Wrap Up: The Latest in Microbiotic Medicinal Products
Editor's Choice

Pharmabiotics 2019 Wrap Up: The Latest in Microbiotic Medicinal Products

MAY 6, 2019
Seres Therapeutics First Quarter Financial Results and Clinical Pipeline Progress
Finance

Seres Therapeutics First Quarter Financial Results and Clinical Pipeline Progress

MAY 5, 2019
5-minute Microbiome Science Roundup: April 2019
Editor's Choice

5-minute Microbiome Science Roundup: April 2019

MAY 4, 2019
4D Pharma Clinical Update on MRx0518 Oncology Programmes
Clinical & Manufacturing

4D Pharma Clinical Update on MRx0518 Oncology Programmes

MAY 1, 2019
Finch Therapeutics Receives Fast Track Designation for the Investigation of Microbiota Treatment for Children with Autism Spectrum Disorder
Gut-Brain Axis

Finch Therapeutics Receives Fast Track Designation for the Investigation of Microbiota Treatment for Children with Autism Spectrum Disorder

MAY 1, 2019
A Bright Outlook for Bacteriophage Applications
Editor's Choice

A Bright Outlook for Bacteriophage Applications

APR 29, 2019
DuPont to Provide Probiotics for International Pediatric Sepsis Research
Biotics and Supplements

DuPont to Provide Probiotics for International Pediatric Sepsis Research

APR 26, 2019
Interview with Nicola Segata, Winner of the Institut Mérieux – Pharmabiotics 2019 YIA Awards
Editor's Choice

Interview with Nicola Segata, Winner of the Institut Mérieux – Pharmabiotics 2019 YIA Awards

APR 17, 2019
Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program
Oncology

Biomica Initiates Pre-clinical Studies in Its Immuno-oncology Program

APR 17, 2019
Microbiome Profiling Techniques Reveal Effects of Iron Fortification on the Infant Gut Microbiome
Editor's Choice

Microbiome Profiling Techniques Reveal Effects of Iron Fortification on the Infant Gut Microbiome

APR 16, 2019